Genetic associations of 115 polymorphisms with cancers of the upper aerodigestive tract across 10 european countries: The ARCAGE project

Cancer Research

Volumn 69, Issue 7, 2009, Pages 2956-2965

  Canova, Cristina ^a   Hashibe, Mia ^b   Simonato, Lorenzo ^a   Nelis, Mari ^c   Metspalu, Andres ^c   Lagiou, Pagona ^d,e   Trichopoulos, Dimitrios ^d,e   Ahrens, Wolfgang ^f   Pigeot, Iris ^f   Merletti, Franco ^g   Richiardi, Lorenzo ^g   Talamini, Renato ^h   Barzan, Luigi ⁱ   Macfarlane, Gary J ^j   Macfarlane, Tatiana V ^j   Holcátová, Ivana ^k   Bencko, Vladimir ^k   Benhamou, Simone ^l,m   Bouchardy, Christine ⁿ   Kjaerheim, Kristina ^o   Lowry, Ray ^p   Agudo, Antonio ^q   Castellsagué, Xavier ^q   Conway, David I ^r,s   McKinney, Patricia A ^s,t   Znaor, Ariana ^u   McCartan, Bernard E ^v   Healy, Claire M ^v   Marron, Manuela ^b   Brennan, Paul ^b   more..

^a UNIVERSITY OF PADOVA   (Italy)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c UNIVERSITY OF TARTU   (Estonia)

^d UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^f UNIVERSITY OF BREMEN   (Germany)

^g UNIVERSITY OF TURIN   (Italy)

^h CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

ⁱ General Hospital of Pordenone   (Italy)

^j UNIVERSITY OF ABERDEEN   (United Kingdom)

^k CHARLES UNIVERSITY   (Czech Republic)

^l INSERM   (France)

^m CNRS   (France)

ⁿ GENEVA CANCER REGISTRY   (Switzerland)

^o CANCER REGISTRY OF NORWAY   (Norway)

^p NEWCASTLE UNIVERSITY   (United Kingdom)

^q CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^r UNIVERSITY OF GLASGOW   (United Kingdom)

^s INFORMATION SERVICES DIVISION   (United Kingdom)

^t UNIVERSITY OF LEEDS   (United Kingdom)

^u CROATIAN NATIONAL INSTITUTE OF PUBLIC HEALTH   (Croatia)

^v TRINITY COLLEGE DUBLIN   (Ireland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 2A6; PROTEIN MDM2; TUMOR NECROSIS FACTOR;

ADULT; AGED; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CELL CYCLE REGULATION; CONTROLLED STUDY; DNA REPAIR; ESOPHAGUS CANCER; EUROPE; FEMALE; GENETIC ASSOCIATION; GENETIC EPIDEMIOLOGY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; LARYNX CANCER; MALE; MOUTH CANCER; PHARYNX CANCER; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SQUAMOUS CELL CARCINOMA; CLINICAL TRIAL; DRINKING BEHAVIOR; ESOPHAGUS TUMOR; GENETIC PREDISPOSITION; GENETICS; HEAD AND NECK TUMOR; LARYNX TUMOR; METABOLISM; MIDDLE AGED; MOUTH TUMOR; MULTICENTER STUDY; SMOKING;

ADULT; AGED; ALCOHOL DRINKING; CASE-CONTROL STUDIES; DNA REPAIR; ESOPHAGEAL NEOPLASMS; EUROPE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEAD AND NECK NEOPLASMS; HUMANS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; PHARYNGEAL NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; SMOKING;

EID: 66149155873     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-2604     Document Type: Article

References (50)

1. Dobrossy L. Epidemiology of head and neck cancer: magnitude of the problem. Cancer Metastasis Rev 2005; 24:9-17.
2. FerlayJ, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide, version 2.0. IARC CancerBase No. 5. Lyon (France): IARC Press; 2004.
3. Parkin DM, Whelan. SL, Ferlay J, Raymond L, Young J. Cancer incidence in five continents, vol.VII. IARC Scientific Publications No. 143. Lyon (France): IARC Press; 1997.
4. IARC monographs on the Evaluation of Carcinogenic Risks to Humans, Vol.83, Lyon, Tobacco smoke and involuntary smoking Lyon (France): IARC Press; 2004.
5. IARC monographs on the evaluation of carcinogenic risks to humans, vol.96. Alcoholic beverage consump- tion and ethyl carbamate (urethane). Lyon (France): IARC Press; 2007.
6. Blot WJ, McLaughlin JK, Winn DM, et al. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res 1988;48:3282-3287.
7. Franceschi S, Talamlnl R1 Barra S1 et al. Smoking and drinking in relation to cancers of the oral cavity, pharynx, larynx, and oesophagus in northern Italy. Cancer Res 1990;50:6502-6507.
8. Costellsague X. Quintana MJ, Martinez MC, et al. The role of type of tobacco and type of alcoholic beverage in oral carcinogenesis. Int J Cancer 2004;108:741-749.
9. Hung RJ, van der Hel O1 Tavtigian SV Brennan P, Boffetta P, Hashibe M. Perspectives on the molecular epidemiology of aerodigestive tract cancers. Mutat Res 2005;592:102-18.
10. Hashibe M1 Boffetta P1 Zaridze D1 et al. Evidence for an important role of alcohol- and aldehyde-metabolizing genes in cancers of the upper aerodigestlve tract. Cancer Epidemiol Biomarkers Prev 2006:15:696-703.
11. Peters ES1 McClean MD1 Liu M1 Eisen EA1 Mueller N1 Kelsey KT. The ADHlC polymorphism modifies the risk of squamous cell carcinoma of the head and neck associated with alcohol and tobacco use. Cancer Epidemiol Biomarkers Prev 2005;14:476-482.
12. Hashibe M1 McKay JD1 Curado MP1 et al. Multiple ADH genes are associated with upper aerodigestlve cancers. Nat Genet 2008;40:707-709.
13. Sanderson S1 Salanti G1 Hlggins J. Joint effects of the JV-acetyltransferase 1 and 2 (NATl and NAT2) genes and smoking on bladder carcinogenesis: a literature-based systematic HuGE review and evidence synthesis. Am J Epidemiol 2007;166:741-51.
14. Morita S1 Yano M1 Tsujinaka Ti et al. Association between genetic polymorphisms of glutathione S- transferase Pl and JV-acetyltronsferase 2 and suscepti- bility to squamous-cell carcinoma of the oesophagus. Int J Cancer 1998:79:517-520
15. Olshan A.F., Weisser MC1 Watson MA1 Bell DA. GSTMI1 GSTTl1 GSTPl1 CYPlAl1 and NATI polymorphisms, tobacco use, and the risk of head and neck cancer. Cancer Epidemiol Biomarkers Prev 2000;9:185-191.
16. Geisler SA, Olshan AF. GSTMl, GSTTl, and the risk of squamous cell carcinoma of the head and neck: a mlni-HuGE review. Am J Epidemiol 2001;154: 95-105.
17. Hashibe M, Brennan P, Strange RC, et al. Meta- and pooled analyses of GSTMl, GSTTl, GSTPl, and CYPlAl genotypes and risk of head and neck cancer. Cancer Epidemiol Biomarkers Prev 2003:12:1509-1517.
18. Sugimura T, Kumimoto H, Tohnai I, et al. Gene- environment interaction involved in oral carcinogenesis: molecular epidemiological study for metabolic and DNA. repair gene polymorphisms. J Oral Pathol Med 2006;35: 11-18.
19. Sturgis EM, Castillo EJ, Li L, et al. Polymorphisms of DNA repair gene XRCCl in squamous cell carcinoma of the head and neck. Carcinogenesis 1999;20:2125-2129.
20. Olshan. AF, Watson MA, Weissler MC, Bell DA. XRCCI polymorphisms and head and neck cancer. Cancer Lett 2002;178:181-186.
21. Sturgis EM, Castillo EJ, Li L, et al. XPD/ERCC2 exon 8 polymorphisms: rarity and lack of significance in risk of squamous cell carcinoma of the head and neck. Oral Oncol 2002;38:475-477.
22. Shen H, Sturgis EM, Dahlstrom KR, Zheng Y, Spitz MR, Wei Q. A variant of the DNA repair gene XRCC3 and risk of squamous cell carcinoma of the head and neck: a case-control analysis. Int J Cancer 2002:99: 869-872.
23. Zheng Y, Shen H, Sturgis EM, et al. Haplotypes of two variants In pl.6 (CDKN2/MTS-l/INK4a) exon. 3 and risk of squamous cell carcinoma of the head and neck: a case-control study. Cancer Epidemiol Biomarkers Prev 2002;11:640-645.
24. Shen H, Zheng Y, Sturgis EM, Spitz MR, Wei Q. P53 codon 72 polymorphism and risk of squamous cell carcinoma of the head. and. neck: a case-control study. Cancer Lett 2002;183:123-30.
25. Hong Y, Miao X, Zhang X, et al. The role of P53 and MDM2 polymorphisms in the risk of oesopha-geal squamous cell carcinoma. Cancer Res 2005:65: 9582-9587.
26. Lagiou P, Georgila C, Minaki P, et al. Alcohol-related cancers and genetic susceptibility in Europe-the ARCAGE project: study samples and data collection. Eur J Cancer Prev 2009:18:76-84.
27. Gemlgnanl F1 Landl S1 Vivant F1 Zlenolddiny S1 Brennan P1 Conzian F. A catalogue of polymorphisms related to xenobiotic metabolism and cancer suscepti- bility. Pharmacogenetics 2002;12:459-463.
28. Landi S1 Gemignani F1 Gioia-Patricola L1 Chabrier A1 Canzian F. Evaluation of a microarray for genotyp- ing polymorphisms related to xenobiotic metabolism and DNA repair. Biotechniques 2003;35:816-20, 822, 824-827.
29. Al Moustafa AE, Alaoui-Jamali MA, Batist G, et al. Identification of genes associated with head and neck carcinogenesis by cDNA microarray compari- son between matched primary normal epithelial and squamous carcinoma cells. Oncogene 2002;21: 2634-2640.
30. Syvanen AC. Accessing genetic variation: genotyplng single nucleotide polymorphisms. Nat Rev Genet 2001;2: 930-942.
31. Kruglyak L, Nickerson DA. Variation is the spice of Ufe. Nat Genet 2001;27:234-236.
32. Kurg A, Tõnisson N, Tollett J, Georglou I, Shumaker J, Metspalu A. Arrayed primer extension: solid phase four- color DNA resequencing and mutation detection technology. Genet Test 2000;4:1-7.
33. Tõnisson N, Kurg A, Kaasik K, Lõhmussaar E, Metspalu A. Unravelling genetic data by arrayed primer extension. Clin Chem Lab Med 2000:38:165-170.
34. Wiggtnton JE, Cutler DJ, Abecasis GR. A note on exact tests of Hardy-Weinberg equilibrium. Am J Hum Genet 2005;76:887-893.
35. Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N. Assessing the probability of false positive reports in molecular epidemiology studies. J Natl Cancer Inst 2004;96:434-442.
36. Guengerich FP, Shimada T. Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chem Res Toxicol 1991;4:391-407.
37. Kamataki T, Fujieda M, Kiyotoni K, Iwano S, Kunitoh H. Genetic polymorphism, of CYP2A6 as one of the potential determinants of tobacco-related cancer risk. Biochem Biophys Res Commun 2005;338: 306-310.
38. Tan W, Chen GF, Xing DY, Song CY, Kadlubar FF, Lin DX Frequency of CYP2A6 gene deletion and its relation to risk, of lung and oesophageal cancer in the Chinese population. Int J Cancer 2001:95:96-101.
39. Nakajima M, Yoshida R, Fukami T, McLeod HL, Yokoi T. Novel human CYP2A6 alleles confound gene deletion analysis. FEBS Lett 2004;569:75-81.
40. Fukami T, Nakajima M, Sakai H, McLeod HL, Yokoi T. CYP2A7 polymorphic alleles confound the genotyping of CYP2A6*4A allele. Pharmacogenomics J 2006;6:401-412.
41. Gemlgnanl F1 Landi S, Szeszenia-Dabrowska N, et al. Development of lung cancer before the age of 50: the role of xenobiotic metabolizing genes. Carcinogenesis 2007;28:1287-1293.
42. Pine SR, Mechanic LE, Bowman ED, et al. MDM2 SNP309 and S.NP354 are not associated with lung cancer risk. Cancer Epidemiol Biomarkers Prev 2006;15:1559-1561.
43. Li G, Zhai X, Zhang Z, Chamberlain RM, Spitz MR, Wei Q, MD.M2 gene promoter polymorphisms and risk of lung cancer: a case-control analysis. Carcinogenesis 2006;27:2028-2033.
44. Balkwill F. Tumor necrosis factor or tumor promot- ing factor? Cytokine Growth Factor Rev 2002;13:135-141.
45. Gaudet MM, Egan KM, Lissowska J, et al. Genetic variation in tumor necrosis factor and lymphotoxin-ct (TNF-LTA) and breast cancer risk. Hum Genet 2007;12.1: 483-490.
46. Yang ZQ, Imoto I, Fukuda Y, et al. Identification of a novel gene, GASCI, within an amplicon at 9p23-24 frequently detected in oesophageal cancer cell lines. Cancer Res 2000;60:4735-4739.
47. Cloos PA, Christensen J, Agger K, et al. The putative oncogene GASCl demethylates tri- and dimethylated lysine 9 on histone H3. Nature 2006;442:307-311.
48. Hu N, Wang C, Hu Y, et al. Genome-wide association study in oesophageal cancer using GeneChip mapping 10K array. Cancer Res 2005;65:2542-2546.
49. Clayton D, McKeigue PM. Epidemiological methods for studying genes and environmental factors in complex diseases. Lancet 2001;358:1356-1360.
50. Hung RJ, McKay JD, Gaborieau V et al. A suscepti- bility locus for lung cancer maps to nicotinic acetyl- choline receptor subunit genes on 15q25. Nature 2008; 452:633-637.